NCT00981227View on ClinicalTrials.gov

Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia

PHASE2CompletedINTERVENTIONAL
Enrollment

567

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Postherpetic Neuralgia
Interventions
DRUG

Eslicarbazepine acetate

Scored tablets

DRUG

Placebo

oral route

All Listed Sponsors
lead

Bial - Portela C S.A.

INDUSTRY

NCT00981227 - Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Post-Herpetic Neuralgia | Biotech Hunter | Biotech Hunter